The long-term outcome of patients with polycystic liver disease treated with lanreotide.

M. Chrispijn; F. Nevens; T.J. Gevers; R. Vanslembrouck; M.G.H. van Oijen; W. Coudyzer; A.L. Hoffmann; H.M. Dekker; R.A. de Man; L. van Keimpema; J.P. Drenth

The long-term outcome of patients with polycystic liver disease treated with lanreotide.

Translated title of the contribution: The long-term outcome of patients with polycystic liver disease treated with lanreotide.

M. Chrispijn, F. Nevens, T.J. Gevers, R. Vanslembrouck, M.G.H. van Oijen, W. Coudyzer, A.L. Hoffmann, H.M. Dekker, R.A. de Man, L. van Keimpema, J.P. Drenth

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	The long-term outcome of patients with polycystic liver disease treated with lanreotide.
Original language	Undefined/Unknown
Pages (from-to)	266-274
Number of pages	9
Journal	Alimentary Pharmacology & Therapeutics
Volume	35
Publication status	Published - 2012

Cite this

@article{dd2e16ba02b84286847a5b8765a971a2,

title = "The long-term outcome of patients with polycystic liver disease treated with lanreotide.",

author = "M. Chrispijn and F. Nevens and T.J. Gevers and R. Vanslembrouck and {van Oijen}, M.G.H. and W. Coudyzer and A.L. Hoffmann and H.M. Dekker and {de Man}, R.A. and {van Keimpema}, L. and J.P. Drenth",

year = "2012",

language = "Undefined/Unknown",

volume = "35",

pages = "266--274",

journal = "Alimentary Pharmacology & Therapeutics",

issn = "0269-2813",

publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - The long-term outcome of patients with polycystic liver disease treated with lanreotide.

AU - Chrispijn, M.

AU - Nevens, F.

AU - Gevers, T.J.

AU - Vanslembrouck, R.

AU - van Oijen, M.G.H.

AU - Coudyzer, W.

AU - Hoffmann, A.L.

AU - Dekker, H.M.

AU - de Man, R.A.

AU - van Keimpema, L.

AU - Drenth, J.P.

PY - 2012

Y1 - 2012

M3 - Article

SN - 0269-2813

VL - 35

SP - 266

EP - 274

JO - Alimentary Pharmacology & Therapeutics

JF - Alimentary Pharmacology & Therapeutics

ER -